Contact

CDMO Services
Explore Resilience’s North American CDMO services: process and analytical development, biologics drug substance manufacturing, sterile fill/finish, device assembly and packaging.
Explore
- Fill/Finish
- Device Assembly, Packing & Logistics
How We Help
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Explore
- Biotech
- Pharma
Facilities
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Explore
Insights
About
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Explore
- Our Team
- Events

News Careers

Contact

Back to Overview

Resilience Expands North American Capacity With The Acquisition Of Two Premier Biologics Manufacturing Facilities

Resilience announces the acquisition of two biologics manufacturing facilities in North America.

Click here to read the original article in Business Wire.

Related Articles

Meet The 24 Biotech Startups That Top VCs Say Are Poised To Take Off In The next 12 Months

Insider asked 12 top VCs to name biotech startups poised to take off in the next 12 months. These startups are...

How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines

While many biopharmaceutical companies are built to fulfill a need, Resilience was built to serve innovation. Founded...

Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy

SAN CARLOS, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage...